The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Carnitine transport: Pathophysiology and metabolism of known molecular defects
Abstract
Summary: Early‐onset dilatative and/or hypertrophic cardiomyopathy with episodic hypoglycaemic coma and very low serum and tissue concentrations of carnitine should alert the clinician to the probability of the plasmalemmal high‐affinity carnitine transporter defect. The diagnosis can be established by demonstration of impaired carnitine uptake in cultured skin fibroblasts or lymphoblasts and confirmed by mutation analysis of the human OCTN2 gene in the affected child and obligate heterozygote parents. The institution of high‐dose oral carnitine supplementation reverses the pathology in this otherwise lethal autosomal recessive disease of childhood, and carnitine therapy from birth in prospectively screened siblings may altogether prevent the development of the clinical phenotype. Heterozygotes may be at risk for cardiomyopathy in later adult life, particularly in the presence of additional risk factors such as hypertension and competitive pharmacological agents. OCTN2 belongs to a family of organic cation/carnitine transporters that function primarily in the elimination of cationic drugs and other xenobiotics in kidney, intestine, liver and placenta. The high‐ and low‐affinity human carnitine transporters, OCTN2 and OCTN1, are multifunctional polyspecific organic cation transporters; therefore, defects in these transporters may have widespread implications for the absorption and/or elimination of a number of key pharmacological agents such as cephalosporins, verapamil, quinidine and valproic acid. A third organic/cation carnitine transporter with high specificity for carnitine, Octn3, has been clonedin mice. The juvenile visceral steatosis (jvs) mouse serves as an excellent clinical, biochemical and molecular model for the high‐affinity carnitine transporter OCTN2 defect and is due to a spontaneous point mutation in the murine Octn2 gene on mouse chromosome 11, which is syntenic to the human locus at 5q31 that harbours the human OCTN2 gene.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More direct evidence linking carnitine imbalance to mitochondrial dysfunction comes from the juvenile visceral steatosis (jvs) mice, a genetic model of primary carnitine deficiency.”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [42]
In the citing paper
“These animals harbor a spontaneous point mutation in OCTN2, resulting in severely depleted tissue carnitine content and marked derangements in mitochondrial genesis and morphology, as well as whole body lipid and energy metabolism (41,42).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [42]
Citations
Cites
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,843
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
The P-loop — a common motif in ATP- and GTP-binding proteins
Saraste, M., Sibbald, P. R., & Wittinghofer, A. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90281-f · Cited by 2,056
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
den Dunnen, J. T., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<45::aid-humu10>3.0.co;2-t · Cited by 1,764
Carnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666
Tamai, I., Ohashi, R., Nezu, J.-I., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20378 · Cited by 697
Bieber, L. L. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001401 · Cited by 623
McGarry, J. D., Mills, S. E., Long, C. S., & Foster, D. W. (1983) · Biochemical Journal · doi:10.1042/bj2140021 · Cited by 556
Nezu, J.-I., Tamai, I., Oku, A., Ohashi, R., Yabuuchi, H., Hashimoto, N., Nikaido, H., Sai, Y., Koizumi, A., Shoji, Y., et al. (1999) · Nature Genetics · doi:10.1038/5030 · Cited by 554
Mechanisms mediating renal secretion of organic anions and cations
Pritchard, J. B., & Miller, D. S. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.4.765 · Cited by 490
Research works printed but not linked: 5
- De Vivo DC, 1990, Primary and secondary disorders of carnitine metabolism, Int Pediatr, 5, 134
- Hamilton JW, 1983, Studies of L‐carnitine absorption in man, Gastroeneterology, 84, 1180
- 10.1002/(SICI)1098-1004(200001)15:1<118::AID-HUMU28>3.0.CO;2-8 · DOI
- 10.1002/(SICI)1098-1004(200003)15:3<238::AID-HUMU4>3.0.CO;2-3 · DOI
- 10.1002/1098-1004(200011)16:5<401::AID-HUMU4>3.0.CO;2-J · DOI
Cited by
Stephens, F. B., Constantin‐Teodosiu, D., & Greenhaff, P. L. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.125799 · Cited by 396
A modern approach to the treatment of mitochondrial disease
The Mitochondrial Medicine Society, Parikh, S., Saneto, R., Falk, M. J., Anselm, I., Cohen, B. H., & Haas, R. (2009) · Current Treatment Options in Neurology · doi:10.1007/s11940-009-0046-0 · Cited by 348
Noland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Schimpf, R., Wolpert, C., Gaïta, F., Giustetto, C., & Borggrefe, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.03.026 · Cited by 184
Enzymology of the carnitine biosynthesis pathway
Strijbis, K., Vaz, F. M., & Distel, B. (2010) · IUBMB Life · doi:10.1002/iub.323 · Cited by 155
Carnitine, mitochondrial function and therapy
Zammit, V. A., Ramsay, R. R., Bonomini, M., & Arduini, A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.024 · Cited by 149
Tamai, I. (2013) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1816 · Cited by 141
THE GENETICS OF PSORIASIS AND AUTOIMMUNITY
Bowcock, A. M. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162324 · Cited by 145
Approaches to the treatment of mitochondrial diseases
DiMauro, S., Hirano, M., & Schon, E. A. (2006) · Muscle & Nerve · doi:10.1002/mus.20598 · Cited by 138
TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE
Alnouti, Y., Petrick, J. S., & Klaassen, C. (2006) · Drug Metabolism And Disposition · doi:10.1124/dmd.105.006932 · Cited by 139
Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics
Wright, S. H. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.021 · Cited by 127
Grube, M., zu Schwabedissen, H. E. M., Draber, K., Präger, D., Möritz, K.-U., Linnemann, K., Fusch, C., Jedlitschky, G., & Kroemer, H. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001560 · Cited by 111
Obesity and lipid stress inhibit carnitine acetyltransferase activity
Seiler, S. E., Martin, O. J., Noland, R. C., Slentz, D. H., DeBalsi, K. L., Ilkayeva, O., An, J., Newgard, C. B., Koves, T. R., & Muoio, D. M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m043448 · Cited by 108
Liang, Z., Chen, F., Park, S., Balasubramanian, B., & Liu, W. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.906084 · Cited by 129
Promoting lipid utilization with l-carnitine to improve oocyte quality
Dunning, K. R., & Robker, R. L. (2012) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2012.08.013 · Cited by 104
Inborn Errors of Metabolism with Myopathy
El‐Gharbawy, A., & Vockley, J. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.11.006 · Cited by 94
Carnitine in metabolic disease: Potential for pharmacological intervention
Arduini, A., Bonomini, M., Savica, V., Amato, A., & Zammit, V. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.008 · Cited by 89
Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability
Olpin, S. E. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9611-5 · Cited by 86
Fingerhut, R., Ensenauer, R. E., Röschinger, W., Arnecke, R., Olgemöller, B., & Roscher, A. A. (2009) · Analytical Chemistry · doi:10.1021/ac8022235 · Cited by 79
Update on pharmacogenetics in epilepsy: a brief review
Szoeke, C. E. I., Newton, M. R., Wood, J. M., Goldstein, D. B., Berkovic, S. F., OBrien, T. J., & Sheffield, L. J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70352-0 · Cited by 78
Crystal structure of the carnitine transporter and insights into the antiport mechanism
Tang, L., Bai, L., Wang, W., & Jiang, T. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1788 · Cited by 70
Akman, H. O., Davidzon, G., Tanji, K., MacDermott, E. J., Larsen, L., Davidson, M. M., Haller, R. G., Szczepaniak, L. S., Lehman, T. J. A., Hirano, M., et al. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.04.004 · Cited by 69
Miecz, D., Januszewicz, E., Czeredys, M., Hinton, B. T., Bérézowski, V., Cecchelli, R., & Nałęcz, K. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05024.x · Cited by 67
Hyperammonemic Encephalopathy Caused by Carnitine Deficiency
Limketkai, B. N., & Zucker, S. D. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0473-0 · Cited by 66
Schlegel, G., Keller, J., Hirche, F., Geißler, S., Schwarz, F. J., Ringseis, R., Stangl, G. I., & Eder, K. (2012) · BMC Veterinary Research · doi:10.1186/1746-6148-8-28 · Cited by 66
Inborn Errors of Energy Metabolism Associated with Myopathies
Das, A. M., Steuerwald, U., & Illsinger, S. (2010) · BioMed Research International · doi:10.1155/2010/340849 · Cited by 68
PPARα agonists up-regulate organic cation transporters in rat liver cells
Luci, S., Geißler, S., König, B., Koch, A. H., Stangl, G. I., Hirche, F., & Eder, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.099 · Cited by 62
Koch, A., König, B., Stangl, G. I., & Eder, K. (2008) · Experimental Biology and Medicine · doi:10.3181/0706-rm-168 · Cited by 61
Hirano, T., Yasuda, S., Osaka, Y., Kobayashi, M., Itagaki, S., & Iseki, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.002 · Cited by 59
Involvement of OCTN2 in the Transport of Acetyl- l -Carnitine across the Inner Blood–Retinal Barrier
Tachikawa, M., Takeda, Y., Tomi, M., & Hosoya, K. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4080 · Cited by 58
Renal Transport of Organic Anions and Cations
Pelis, R. M., & Wright, S. H. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100084 · Cited by 58
Rasmussen, J., Nielsen, O. W., Lund, A. M., Køber, L., & Djurhuus, H. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9488-8 · Cited by 60
Functional Genetic Diversity in the High-Affinity Carnitine Transporter OCTN2 (SLC22A5)
Urban, T. J., Gallagher, R. C., Brown, C., Castro, R. A., Lagpacan, L. L., Brett, C. M., Taylor, T. R., Carlson, E. J., Ferrin, T. E., Burchard, E. G., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028126 · Cited by 56
Tragni, V., Primiano, G., Tummolo, A., Beltrame, L. C., Piana, G. L., Sgobba, M. N., Cavalluzzi, M. M., Paterno, G., Gorgoglione, R., Volpicella, M., et al. (2022) · Molecules · doi:10.3390/molecules27113494 · Cited by 57
Ringseis, R., Wege, N., Wen, G., Rauer, C., Hirche, F., Kluge, H., & Eder, K. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.07.012 · Cited by 55
Wu, Y., Wu, S., & Wei, Y. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140306103401 · Cited by 55
Significance of Levocarnitine Treatment in Dialysis Patients
Takashima, H., Maruyama, T., & Abe, M. (2021) · Nutrients · doi:10.3390/nu13041219 · Cited by 53
Lagace, D. C., McLeod, R. S., & Nachtigal, M. W. (2004) · Endocrinology · doi:10.1210/en.2004-0877 · Cited by 50
Schlereth, T., Birklein, F., Haack, K., Schiffmann, S., Kilbinger, H. J., Kirkpatrick, C. J., & Wessler, I. K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706451 · Cited by 48
D’Argenio, G., Petillo, O., Margarucci, S., Torpedine, A., Calarco, A., Koverech, A., Boccia, A. S., Paolella, G., & Peluso, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109678 · Cited by 43
Takahashi, R., Asai, T., Murakami, H., Murakami, R., Tsuzuki, M., Numaguchi, Y., Matsui, H., Murohara, T., & Okumura, K. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.088609 · Cited by 43
OCTN3: A Na+‐independent L ‐carnitine transporter in enterocytes basolateral membrane
Durán, J. M., Rubio, M. J. P., Calonge, M. L., & Ilundáin, A. A. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20193 · Cited by 41
L ‐Carnitine– L ‐tartrate promotes human hair growth in vitro
Foitzik, K., Hoting, E., Förster, T., Pertile, P., & Paus, R. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00611.x · Cited by 40
Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures
Rodrigues, R. M., Kollipara, L., Chaudhari, U., Sachinidis, A., Zahedi, R. P., Sickmann, A., Kopp‐Schneider, A., Jiang, X., Keun, H. C., Hengstler, J. G., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2214-z · Cited by 40
Dietary L ‐carnitine alters gene expression in skeletal muscle of piglets
Keller, J., Ringseis, R., Priebe, S., Guthke, R., Kluge, H., & Eder, K. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000293 · Cited by 41
Tahara, H., Yee, S. W., Urban, T. J., Hesselson, S., Castro, R. A., Kawamoto, M., Stryke, D., Johns, S. J., Ferrin, T. E., Kwok, P., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146449 · Cited by 38
Carnitine Deficiency Increases Susceptibility to Bupivacaine-induced Cardiotoxicity in Rats
Wong, G. K., & Crawford, M. W. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31821a8d46 · Cited by 35
Ringseis, R., Luci, S., Spielmann, J., Kluge, H., Fischer, M., Geißler, S., Wen, G., Hirche, F., & Eder, K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.008 · Cited by 35
Rasmussen, J., Køber, L., Lund, A. M., & Nielsen, O. W. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9640-0 · Cited by 37
Eder, K., & Ringseis, R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.042 · Cited by 36
Luci, S., Hirche, F., & Eder, K. (2008) · Annals of Nutrition and Metabolism · doi:10.1159/000118872 · Cited by 34
Ringseis, R., Wen, G., & Eder, K. (2012) · PPAR Research · doi:10.1155/2012/868317 · Cited by 32
Diao, L., Ekins, S., & Polli, J. E. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100226q · Cited by 32
Renal Handling of Organic Solutes
Moe, O. W., Wright, S. H., & Palacín, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10008-9 · Cited by 33
Genetics and metabolic cardiomyopathies
Wicks, E. C., & Elliot, P. M. (2012) · Herz · doi:10.1007/s00059-012-3659-0 · Cited by 32
Pasqua, T., Rocca, C., Giglio, A., & Angelone, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040721 · Cited by 31
Koch, A. H., König, B., Luci, S., Stangl, G. I., & Eder, K. (2007) · British Journal Of Nutrition · doi:10.1017/s000711450775691x · Cited by 31
Acetyl-l-carnitine increases mitochondrial protein acetylation in the aged rat heart
Kerner, J., Yohannes, E., Lee, K., Virmani, A., Koverech, A., Cavazza, C., Chance, M. R., & Hoppel, C. L. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.01.003 · Cited by 27
Biochemical factors limiting myocardial energy in a chicken genotype selected for rapid growth
Nain, S., Ling, B., Alcorn, J., Wojnarowicz, C., Laarveld, B., & Olkowski, A. A. (2007) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2007.10.001 · Cited by 29
Shekhawat, P., Yang, H.-S., Bennett, M. J., Carter, A. L., Matern, D., Tamai, I., & Ganapathy, V. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000134252.02876.55 · Cited by 28
Increased Insulin Sensitivity in Mice Lacking Collectrin, a Downstream Target of HNF-1α
Malakauskas, S. M., Kourany, W. M., Zhang, X. Y., Lu, D., Stevens, R. D., Koves, T. R., Hohmeier, H. E., Muoio, D. M., Newgard, C. B., & Le, T. H. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0274 · Cited by 28
Modulatory Effects of l‐Carnitine on Glucocorticoid Receptor Activity
Manoli, I., Martino, M. U. D., Kino, T., & Alesci, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.014 · Cited by 29
Influence of l -carnitine on metabolism and performance of sows
Eder, K. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509990778 · Cited by 28
Effect of L-carnitine on the hepatic transcript profile in piglets as animal model
Keller, J., Ringseis, R., Priebe, S., Guthke, R., Kluge, H., & Eder, K. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-76 · Cited by 26
The adverse effects of long-term l -carnitine supplementation on liver and kidney function in rats
Liu, L., Zhang, D.-M., Mx, W., Fan, C.-Y., Zhou, F., Wang, S.-J., & Kong, L.-D. (2015) · Human & Experimental Toxicology · doi:10.1177/0960327115571767 · Cited by 27
Ringseis, R., & Eder, K. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.016 · Cited by 24
Carnitine is necessary to maintain the phenotype and function of brown adipose tissue
Ozaki, K., Sano, T., Tsuji, N., Matsuura, T., & Narama, I. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.6 · Cited by 25
Zhong, H., Li, H., Liu, G., Wan, H., Mercier, Y., Zhang, X., Lin, Y., Che, L., Xu, S., Tang, L., et al. (2016) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-016-0103-y · Cited by 24
Genetic Variations of the SLC22A5 Gene in the Chinese and Indian Populations of Singapore
Toh, D. S. L., Yee, J. Y., Koo, S. H., Murray, M., & Lee, E. J. D. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.112 · Cited by 23
Diao, L., & Polli, J. E. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22557 · Cited by 23
A moderate excess of dietary lysine lowers plasma and tissue carnitine concentrations in pigs
Fischer, M., Hirche, F., Kluge, H., & Eder, K. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508994770 · Cited by 23
Fischer, M., Varady, J., Hirche, F., Kluge, H., & Eder, K. (2009) · Archives of Animal Nutrition · doi:10.1080/17450390802611636 · Cited by 23
Carnitine Membrane Transporter Deficiency: A Rare Treatable Cause of Cardiomyopathy and Anemia
Cano, A., Ovaert, C., Vianey‐Saban, C., & Chabrol, B. (2007) · Pediatric Cardiology · doi:10.1007/s00246-007-9051-9 · Cited by 22
Erbaş, H., Aydoĝdu, N., Usta, U., & Erten, O. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.06.007 · Cited by 22
Serum and Muscle Carnitine Levels in Epileptic Children Receiving Sodium Valproate
Anıl, M., Helvaci, M., Ozbal, E., Kalenderer, Ö., Anıl, A. B., & Dilek, M. (2009) · Journal of Child Neurology · doi:10.1177/0883073808321060 · Cited by 20
Renal Organic Cation and Anion Transport: From Physiology to Genes
Sweet, D. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00802-2 · Cited by 19
Broderick, T. L. (2006) · Drugs in R&D · doi:10.2165/00126839-200607030-00002 · Cited by 19
Gutgesell, A., Ringseis, R., Brandsch, C., Stangl, G. I., Hirche, F., & Eder, K. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.018 · Cited by 18
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
Bonomini, M., Liberato, L. D., Zammit, V. A., & Arduini, A. (2019) · Molecules · doi:10.3390/molecules24193449 · Cited by 18
IntestinalTransporters in Drug Absorption
Bhardwaj, R., Herrera‐Ruiz, D., Yan, X., Carl, S. M., Cook, T. J., Vorsa, N., & Knipp, G. T. (2007) · Springer eBooks · doi:10.1007/978-0-387-72379-2_7 · Cited by 16
Rasmussen, J., Thomsen, J. A., Olesen, J. H., Lund, T. M., Mohr, M., Clementsen, J., Nielsen, O. W., & Lund, A. M. (2014) · JIMD Reports · doi:10.1007/8904_2014_398 · Cited by 16
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia
Bonomini, M., Sirolli, V., Dottori, S., Amoroso, L., Liberato, L. D., & Arduini, A. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm212 · Cited by 16
Sharma, B., Schmidt, L., Nguyen, C., Kiernan, S. R., Dexter-Meldrum, J., Kuschner, Z. D., Ellis, S., Bhatia, N. D., Agriantonis, G., Harris, J. W., et al. (2024) · Metabolites · doi:10.3390/metabo14070363 · Cited by 15
Ayyat, M. S., El-Latif, K. M. A., Helal, A., & Al-Sagheer, A. A. (2021) · Tropical Animal Health and Production · doi:10.1007/s11250-021-02723-1 · Cited by 15
Dionne, S., Elimrani, I., Roy, M.-J., Qureshi, I. A., Sarma, D. S. R., Levy, E. H., & Seidman, E. G. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.722247 · Cited by 13
Nakahara, S., Arimura, Y., Saito, K., Goto, A., Motoya, S., Shinomura, Y., Miyamoto, A., & Imai, K. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9208-5 · Cited by 14
Primary Carnitine Deficiency: Is Foetal Development Affected and Can Newborn Screening Be Improved?
Rasmussen, J., HOUGAARD, D. M., Sandhu, N., Fjællegaard, K., Petersen, P. R., Steuerwald, U., & Lund, A. M. (2017) · JIMD Reports · doi:10.1007/8904_2016_30 · Cited by 13
Effect of intravenous l-carnitine in Chinese patients with chronic heart failure
Jing, Z., Wu, B., Peng, J., Li, X., Pan, L., Zhao, S., Li, D., Yu, Z., Gong, J., Zhao, Q., et al. (2016) · European Heart Journal Supplements · doi:10.1093/eurheartj/suw008 · Cited by 11
A novel mouse model of X-linked cardiac hypertrophy
Leatherbury, L., Yu, Q., Chatterjee, B., Walker, D. L., Yu, Z., Tian, X., & Lo, C.-C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00160.2007 · Cited by 11
Effects of fish oil and conjugated linoleic acids on carnitine homeostasis in laying hens
Shibani, M., Keller, J., König, B., Kluge, H., Hirche, F., Stangl, G. I., Ringseis, R., & Eder, K. (2012) · British Poultry Science · doi:10.1080/00071668.2012.713464 · Cited by 8
Cardiología pediátrica en la era de la genómica
Marín-García, J. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77112-2 · Cited by 8
STOCKER, S. L., Riedmaier, A. E., Schwab, M. G., & Giacomini, K. M. (2013) · Wiley eBooks · doi:10.1002/9781118353240.ch8 · Cited by 8
Pericardial effusion in primary systemic carnitine deficiency
Wattanasirichaigoon, D., Khowsathit, P., Visudtibhan, A., Suthutvoravut, U., Charoenpipop, D., Kim, S. Z., Levy, H. L., & Shih, V. E. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0335-7 · Cited by 7
Plasma carnitine ester profile in homozygous and heterozygous OCTN2 deficiency
Komlósi, K., Magyari, L., Talián, G. C., Nemes, É., Káposzta, R., Mogyorósy, G., Méhes, K., & Melegh, B. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-0926-1 · Cited by 7
Dai, N., Diao, Z., Huang, H., Li, Z., Yang, R., & Liu, W. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.07.019 · Cited by 6
Pyruvate Dehydrogenase, Pyruvate Carboxylase, Krebs Cycle and Mitochondrial Transport Disorders
Tondo, M., Marin‐Valencia, I., Ma, Q., & Pascual, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00025-5 · Cited by 7
Chidambaram, S. B., Bhat, A., Mahalakshmi, A. M., Ray, B., Tuladhar, S., Sushmitha, B. S., Saravanan, B., Manivasagam, T., Thenmozhi, A. J., Essa, M. M., et al. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_20 · Cited by 6
Carnitine Deficiency in Pregnancy
Donnelly, C., Hameed, A. B., Abdenur, J. E., & Wing, D. A. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000258786.94283.d9 · Cited by 6
Mitochondrial Dysfunction and Chronic Fatigue Syndromes: Issues in Clinical Care (modified version)
Singh, T. B., & Singh, K. R. (2014) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-13553033 · Cited by 4
Pyruvate dehydrogenase, pyruvate carboxylase, Krebs cycle, and mitochondrial transport disorders
Jakkamsetti, V., Ma, Q., Marin‐Valencia, I., & Pascual, J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00050-9 · Cited by 4
Metadata
- Authors
- Tein, I.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Tein, I.
- ORCID
- Tein, I.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2003-03
- Volume
- 26
- Issue
- 2-3
- Pages
- 147-169
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1569055531
- Cited by
- 140
- References
- 124
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 6 · 2012: 11
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- carnitine transport, OCTN2, OCTN1, carnitine deficiency, cardiomyopathy, hypoglycemic coma, organic cation transporters, carnitine supplementation, autosomal recessive inheritance, drug transport, cephalosporins, verapamil, quinidine, valproic acid, genotype-phenotype correlation
- MeSH terms
- Solute Carrier Family 22 Member 5, Animals, Biological Transport, Carnitine, Carrier Proteins, Disease Models, Animal, Humans, Membrane Proteins, Mutation, Valproic Acid, Membrane Transport Proteins, Organic Cation Transport Proteins, Symporters, Mice, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.